Related Experiment Videos
Chronic hepatitis C and liver transplantation
1Division of Hepatology, Baylor University Medical Center, Dallas, Texas, USA.
Reviews in Gastroenterological Disorders
|March 19, 2004
Summary
Chronic hepatitis C virus (HCV) infection causes liver cirrhosis, often necessitating liver transplants. Recurrent HCV post-transplant leads to rapid fibrosis, posing significant challenges for long-term graft survival.
Area of Science:
- Hepatology
- Transplantation Immunology
- Viral Hepatitis
Background:
- Chronic hepatitis C virus (HCV) infection is a global health concern, affecting millions worldwide.
- Cirrhosis complications from HCV are increasing, driving a significant portion of liver transplantations.
- HCV recurrence post-transplantation is universal, leading to rapid fibrosis and graft loss.
Purpose of the Study:
- To review strategies for mitigating HCV recurrence after liver transplantation.
- To discuss the challenges and ethical considerations of retransplantation in the MELD system era.
Main Methods:
- Literature review of strategies to prevent HCV recurrence post-transplantation.
- Analysis of outcomes and ethical implications of liver retransplantation under the MELD system.
Main Results:
- HCV recurrence is common after liver transplantation, with rapid progression of liver disease.
- Antiviral treatments for recurrent HCV are difficult to administer and often require dose reduction.
- Retransplantation survival rates are low, and the MELD system presents ethical challenges regarding resource allocation.
Conclusions:
- Effective strategies are needed to manage recurrent HCV infection and improve graft survival post-transplantation.
- The current MELD system poses ethical dilemmas for liver retransplantation due to poor outcomes and resource limitations.